Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1105 of 5804
-
New suction device aims to clear dangerous leg clots
Disease control Recruiting nowThe primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of thrombus in patients with lower extremity proximal deep vein thrombosis (DVT). This prospective, multi-center, open-label …
Sponsor: Argon Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New inhaled insulin combo aims to simplify diabetes care for teens
Disease control Recruiting nowINHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also ev…
Phase: PHASE2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Botox-Like shot may simplify hernia repair, early trial hopes
Disease control Recruiting nowA ventral hernia happens when the muscles in the front of your belly become weak and let organs push through, causing a bulge. If it gets worse, intestines can slip into the bulge, leading to serious pain and health problems. This study aims to asses if AGN-151607-DP is safe and …
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a Mucus-Busting supplement boost an IBS drug?
Symptom relief Recruiting nowThe purpose of this study is to examine the effectiveness of using a combination of a drug, rifaximin and a dietary supplement, N-acetyl-L-cysteine (NAC), to treat patients with irritable bowel syndrome with diarrhea (IBS-D). Rifaximin is one of the standard treatments for IBS-D …
Phase: PHASE2 • Sponsor: Mark Pimentel, MD • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Brain zaps and brain games: new hope for opioid recovery?
Disease control Recruiting nowThe overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).
Phase: PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could CAR-T cells tame severe colitis? early trial launches
Disease control Recruiting nowA Single-Center, Open-Label, Single-Arm Exploratory Clinical Study on the Use of Autologous CAR-T Cell Therapy Injection for the Treatment of Refractory and Relapsing Ulcerative Colitis: A Preliminary Exploration of 12-Week Clinical Remission with Autologous CAR-T Cell Injection …
Phase: EARLY_PHASE1 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Family-Focused program aims to cut diabetes risk in black communities
Prevention Recruiting nowThis study will provide evidence for the utility of using a community-engaged research approach to implement a tailored, family-oriented adaptation of the Diabetes Prevention Program that will have positive effects on risk factors associated with type 2 diabetes morbidity and mor…
Phase: NA • Sponsor: Morehouse School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Could some AML patients ditch chemo pills after a year?
Disease control Recruiting nowThe goal of this clinical trial is to test efficacy and safety of a VENETOCLAX-AZACITIDINE (VEN-AZA) de-escalation strategy in Acute Myeloid Leukemia responding patients. The main objectives of the study are: * Evaluation of the efficacy of VEN-AZA de-escalation strategy by meas…
Phase: PHASE2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
AI predicts who is cancer-free after rectal cancer treatment
Knowledge-focused OngoingThis study aims to develop and validate a robust machine learning-based prediction model utilizing baseline clinical data and magnetic resonance imaging (MRI) features. The objective is to preoperatively predict the probability of achieving a pathological complete response (pCR) …
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Could a low dose of ketamine curb opioid cravings?
Disease control Recruiting nowThe goal of this clinical trial is to learn if ketamine works to reduce craving for opioids in adults entering methadone treatment for opioid use disorder. The main questions it aims to answer are: * Does ketamine reduce craving for opioids in patients with opioid use disorder? …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental gene injection aims to save sight in rare retinal disorder
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of PUMCH-E111 injection in subjects with RLBP1 related Inherited Retinal Dystrophy.
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill could soothe severe eczema – trial underway
Disease control Recruiting nowThis clinical trial aims to explore whether the drug ZL-82 tablets can be used to treat moderate to severe atopic dermatitis in adults, and to understand the safety and tolerability of the drug. The main questions that the trial intends to answer are: Can ZL-82 tablets alleviate …
Phase: PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could two common drugs stop Opioid-Induced nausea in cancer patients?
Prevention Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of olanzapine plus metoclopramide in preventing opioid-induced nausea and vomiting (OINV) in adult patients with advanced cancer who are initiating strong opioid therapy. The main questions it aims to answer a…
Phase: PHASE3 • Sponsor: Affiliated Hospital of Qinghai University • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
New drug could stop knee infections after replacement
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether the investigational drug PLG0206 can help reduce recurrence of infection in adults who have undergone total knee replacement and are receiving a DAIR (Debridement, Antibiotics, and Implant Retention) surgical procedure to tre…
Phase: PHASE2, PHASE3 • Sponsor: Peptilogics • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New trial aims to improve radiation for large brain tumors
Disease control Recruiting nowThis is a randomized, phase II trial comparing staged stereotactic radiosurgery (SSRS) versus fractionated stereotactic radiotherapy (FSRT) in patients with large brain metastases (≥2 cm and ≤5 cm). The study aims to evaluate efficacy, safety, and tumor response between these two…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Simple blood test could spot three cancers before symptoms appear
Diagnosis Recruiting nowThe goal of this clinical trial is to develop a new cancer diagnostic and prognostic tool based on the dynamic and non-invasive detection of an exogenous volatile molecule, i.e., ethanol, from patients' samples. Patients' blood plasma will be analyzed with a mixture of volatile …
Phase: EARLY_PHASE1 • Sponsor: Poitiers University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
New combo therapy targets tough lung cancer in early trial
Disease control Recruiting nowThe purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refractory Small Cell Lung Cancer
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New pill could tame Flare-Ups for ulcerative colitis patients
Disease control Recruiting nowThe purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could a simple protein infusion limit stroke damage?
Disease control Recruiting nowA single-center, open-label, randomized, placebo-controlled, prospective phase II clinical trial to investigate the efficacy of low-dose albumin in patients with ischemic stroke with an indication for vasographic intervention. The clinical trial consists of the following phases: …
Phase: PHASE2 • Sponsor: University Hospital Hradec Kralove • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental CAR-T therapy targets tough autoimmune blood diseases
Disease control Recruiting nowThis is a single-arm, open-label, investigator-initiated trial (IIT) designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of RD06-05 in subjects with autoantibody-mediated autoimmune hematological diseases. The enrolled populat…
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC